Immunocore Holdings Ltd (IMCR)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 1.63B
P/E Ratio
0.00
Revenue (TTM)
$ 356.14M
Volume
0
52W High
$ 39.33
52W Low
$ 23.15
Dividend Yield
0.00%
Beta
0.78
Technicals
50-Day MA
33.6975
200-Day MA
31.3024
52 Week High
39.3295
52 Week Low
23.15
About IMCR
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KI.
Employees
493
Headquarters
Abingdon, United Kingdom
CEO
Dr. Bahija Jallal Ph.D.